Lilly's Verzenio bags third breast cancer nod - PharmaTimes

Eli Lilly’s Verzenio has been given another green light in the US for breast cancer, significantly expanding the drug’s treatment scope.

Breast cancer drug approved for NHS after maker agrees discount

Elizabeth Grant Retinologist Wonder Set

With $8B Acquisition of Loxo, Lilly Catches Up in Cancer via

Lilly's Verzenio bags third breast cancer nod - PharmaTimes

Lilly presents five-year outcomes for Verzenio in early breast cancer

Novocure's tumor-treating electric fields fail phase 3 trial in

Breast cancer drug Verzenio could have serious side effects on

Health Canada Authorizes Verzenio® (abemaciclib) as the First and

Verzenio® (abemaciclib) Significantly Extends Life by a Median of

China's Approval of Eli Lilly's Verzenios is Extended in Breast

Elizabeth Grant Retinologist Wonder Set

Lilly Contract Pharma

Eli Lilly, with latest Verzenio nod, teams up with a host of

Lilly's Verzenio expands indication for high-risk early breast

Novartis' Kisqali, trailing Lilly's Verzenio, nabs limited NICE